课题基金 / 基金详情

Effects of oxidized low density lipoprotein on vascular endothelial and smooth muscle cells

Effects of oxidized low density lipoprotein on vascular endothelial and smooth muscle cells
氧化低密度脂蛋白对血管内皮和平滑肌细胞的影响
批准号:
03670460
负责人:
KUGIYAMA Kiyotaka
金额:
$1.54万
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (C)
财政年份:
1991
资助国家:
日本
项目状态:
已结题
起止时间:
1991 至 1992

项目摘要

项目成果

KUGIYAMA Kiyotaka的其他基金

相似基金

相关文献

中文摘要
翻译
溶血磷脂酰胆碱(LPC)从氧化修饰的低密度脂蛋白(Ox-LDL)转移到内皮表面膜,在兔主动脉和猪冠状动脉中对细胞表面受体调节的内皮依赖性松弛(EDR)产生选择性不反应。为了确定其机制,研究了LPC或Ox-LDL对内皮细胞内信号的影响。本实验结果表明,LPC抑制内皮细胞早期跨膜信号通路,蛋白激酶C (PKC)的激活可能至少部分参与了LPC的负调控。LPC的这些细胞内作用可能在LPC诱导EDR损伤响应细胞表面受体介导的刺激的机制中发挥作用。为了确定Ox-LDL是否调节内皮纤维蛋白溶解系统,采用ELISA法测定条件培养基中纤溶酶原激活物抑制剂-1 (PAI-1)和组织型纤溶酶原激活物(t-PA) a的水平。结果表明,Ox-LDL通过Ox-LDL中可转移的亲水脂质(s)刺激PAI-1释放,尤其是LPC,而Ox-LDL抑制25-羟基胆固醇和7-酮胆固醇或其他可转移的脂质(s)从Ox-LDL到白蛋白而不是LPC释放t-PA。因此,Ox-LDL中的脂质产物可能损害内皮纤维蛋白溶解。我们进一步研究了Ox-LDL对培养血管内皮细胞(猪主动脉内皮细胞和人脐静脉内皮细胞)分泌内皮素-1样免疫反应性(ET-1- li)的影响,考虑ET-1与动脉粥样硬化和高胆固醇血症的可能相关性。结果表明,Ox-LDL中的LPC会抑制ET-1-LI的释放,这可能会抵消动脉粥样硬化的血管收缩特性。此外,Ox-LDL中的LPC导致内皮对多形核白细胞(PMNs)的粘附性增加,从而增加了PMNs诱导的猪冠状动脉EDR损伤。这是由于猪冠状动脉内皮细胞间粘附分子-1的表达增加,而LPC在Ox-LDL中激活PKC可能至少部分参与了这些机制。少
英文摘要
Lysophosphatidylcholine (LPC) transferred from oxidatively modified low density lipoprotein (Ox-LDL) to the endothelial surface membrane has been shown to produce a selective unresponsiveness to cell surface receptor-regulated endothelium-dependent relaxation (EDR) in the rabbit aorta and porcine coronary artery. To determine its mechanism, the effects of LPC or Ox-LDL on intracellular signals in endothelial cells were examined. The results from this experiment indicate that LPC inhibits the early transmembrane signaling pathway in endothelial cells, and Protein Kinase C (PKC) activation could at least partially be involved in the negative regulation by LPC. These intracellular actions of LPC may play a role in the mechanism of the LPC-induced impairment of EDR in response to cell surface receptor-mediated stimulations.To determine whether Ox-LDL modulates endothelial fibrinolytic system, levels of plasminogen activator inhibitor-1 (PAI-1) and tissue-type plasminogen activator (t-PA) a … More ntigens in the conditioned medium were measured by ELISA. The results indicate that Ox-LDL stimulates PAI-1 release by the transferable hydrophilic lipid(s) in Ox-LDL, especially LPC, while Ox-LDL inhibits t-PA release by 25-hydroxycholesterol and 7-ketocholesterol or other transferable lipid(s) from Ox-LDL to albumin rather than LPC. Thus, lipid products in Ox-LDL may impair endothelial fibrinolysis. We further examined the effects of Ox-LDL on the secretion of endothelin-1-like immunoreactivity (ET-1-LI) by the cultured vascular endothelial cells (porcine aortic endothelial cells and human umbilical vein endothelial cells), considering the possible relevance of ET-1 to the atherosclerosis and hypercholesterolemia. The results show that LPC in Ox-LDL causes suppression of ET-1-LI release, which may counteract the vasoconstricitve properties of atherosclerotic arteries. Furthermore, LPC in Ox-LDL causes the increase of the endothelial adhesiveness to polymorphonuclear leukocytes (PMNs), which augments PMNs-induced impairment of EDR in porcine coronary artery. This is due to increased expression of intercellular adhesion molecule-1 in endothelium of the porcine coronary artery, and the activation of PKC by LPC in Ox-LDL may at least in part be involved in these mechanisms. Less
期刊论文(19)
专著(0)
科研奖励(0)
会议论文
Michihisa Jougasaki et al.: "Suppression of endothelin-1 secretion by lysophosphatidylcholine in oxidized low density lipoprotein in cultured vascular endothelial cells" Circulation Research. 71. 614-619 (1992)
Michihisa Jougasaki 等人:“培养血管内皮细胞中氧化低密度脂蛋白中溶血磷脂酰胆碱对内皮素 1 分泌的抑制”循环研究。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Kiyotaka Kugiyam,et al.: "Stimulation of plasminogen activator inhibitor-1 (PAI-1) and inhibition of tissue plasminogen activator (tPA) release from endothelial cells by lipid products in oxidized LDL (Ox-LDL)" Circulation. 86 suppl.I. 211 (1992)
Kiyotaka Kugiyam 等人:“氧化 LDL (Ox-LDL) 中的脂质产物刺激纤溶酶原激活剂抑制剂-1 (PAI-1) 并抑制内皮细胞释放组织纤溶酶原激活剂 (tPA)”。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Kiyotaka Kugiyama,et al.: "Lysophosphatidylcholine inhibits surface receptor-mediated intra-cellular signals in endothelial cells by a pathway involving protein kinase C activation" Circulation Research. 71. 1422-1428 (1992)
Kiyotaka Kugiyama 等人:“溶血磷脂酰胆碱通过涉及蛋白激酶 C 激活的途径抑制内皮细胞中表面受体介导的细胞内信号”循环研究。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Michihisa Jougasaki, et al.: "Suppression of endothelin-l secretion by lysophosphatidylcholine in oxidized low density lipoprotein in cultured vascular endothelial cells" Circulation Research. 71. 614-619 (1992)
Michihisa Jougasaki 等人:“培养的血管内皮细胞中氧化低密度脂蛋白中溶血磷脂酰胆碱对内皮素-1 分泌的抑制”循环研究。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 17 条
    A study of role of phospholipase A2 receptor in pathogenosis ofcardiovascular diseases and development of new drug for cardiovascular diseases
    • 批准号:
      22390158
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.98万
    • 财政年份:
      2010
    • 负责人:
      KUGIYAMA Kiyotaka
    • 依托单位:
    A study of role of phospholipase A2 in pathogenosis of cardiovascular diseases and development of new drug for cardiovascular diseases
    • 批准号:
      19390209
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.56万
    • 财政年份:
      2007
    • 负责人:
      KUGIYAMA Kiyotaka
    • 依托单位:
    Clinical significance of remnant lipoproteinemia as a therapeutic target of cardiovascular diseases
    • 批准号:
      15390244
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $9.6万
    • 财政年份:
      2003
    • 负责人:
      KUGIYAMA Kiyotaka
    • 依托单位:
    Role of polymorphisms of γ-glutamylcysteine synthetase genes in pathogenesis of coronary spastic angina
    海外基金